Pathogenic BRCA2 variants are associated with an increased risk of other cancers, including ovarian and pancreatic cancer identified as an important consideration for surveillance in the Kenyan patient who was eligible for return of research results (Kopanos et al., 2018). The gene discussed is BRCA2; the disease is pancreatic neoplasm.